S-1 · primary offering
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Surgical & Medical Instruments & ApparatusIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 44 of RenovoRx, Inc.'s SEC filings and found 17 warrant series, 1 ATM program, 5 shelf registrations, 2 S-1 registrations and 1 completed offering on file for RNXT. The latest dilution event on file is a registration statement on May 15, 2026. Analysis updated Oct 17, 2026.
Raise routes on file: effective shelf + pending S-1 · latest dilution event 172 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
May 15, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Proposed maximum
Shares registered
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Issued 2021
Shares Underlying
Exercise Price
Issued 2021
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2025
Total capacity
Sold to date
Issued 2022
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z